Tuesday, June 30, 2026 | 11:36 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lupin Ltd Quarterly Results

Q4 FY25-26 Results Summary

Revenue

The revenue stands at ₹7,474.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.29 per cent from ₹7,167.52 crore. This corresponds to a year-on-year *(YoY) growth of 31.89 per cent.

Operating Profit

Operating Profit stands at ₹2,354.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.28 per cent from ₹1,835.28 crore. This corresponds to a year-on-year *(YoY) growth of 78.19 per cent.

PBDT

PBDT stands at ₹2,374.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.42 per cent from ₹1,835.00 crore. This corresponds to a year-on-year *(YoY) growth of 84.23 per cent.

Profit Before Tax

Profit Before Tax stands at ₹1,928.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.67 per cent from ₹1,522.04 crore. This corresponds to a year-on-year *(YoY) growth of 115.22 per cent.

Net Profit

Net Profit stands at ₹1,468.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.41 per cent from ₹1,180.51 crore. This represents a 87.72 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Lupin Ltd Earnings

Data not available

Lupin Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Lupin Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 2,500Emkay Global16-Feb-2026
Accumulate 2,200Kotak Securities10-Oct-2025
Neutral 2,000Motilal Oswal07-Aug-2025
Accumulate 2,392Elara Capital16-May-2025
Accumulate 2,392Elara Capital11-Nov-2024

Lupin Ltd Financial Reports

Filter By:
Loading...

Lupin Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Lupin0.58%2.21%7.09%6.45%14.59%23.40%
Cipla1.00%2.13%5.55%22.75%-2.84%-3.16%
Dr Reddy's Labs-1.41%2.15%5.24%12.21%6.75%6.26%
Zydus Lifesci.-0.82%1.19%1.96%28.81%21.60%11.06%
Mankind Pharma2.81%2.99%9.90%27.43%16.10%11.41%
Aurobindo Pharma1.55%3.02%10.01%17.42%33.41%39.15%
Laurus Labs1.14%4.54%9.48%46.26%37.16%103.75%

Company Info

Company Information

Chairman (Non-Executive) : M D Gupta

Managing Director : Nilesh Deshbandhu Gupta.

Director & Chief Executive Officer : Vinita Gupta

Company Sec. & Compli. Officer : R V Satam

Independent Director : Jean-Luc Belingard

Director & Group CFO : Ramesh Swaminathan

Independent Director : Mark D McDade

Independent Director : K B S Anand

Independent Director : Jeffrey Kindler

Independent Director : Alfonso Zulueta

Independent Director : Punita Lal

Lupin Ltd News

Data Not Available